Last week, the 2025 WuXi Global Forum brought together thousands of leaders, innovators, and visionaries from around the world to share ideas and spark meaningful collaborations. Today, we’re excited to share the digital premiere of the event, including highlights from the opening plenary, with over 120 executive roundtables led by C-Suite leaders. Join us in celebrating the progress we’ve made and the shared journey that unites us all in transforming patients’ lives. Every Innovation Story Matters: https://lnkd.in/dcYz_nEc
药明康德
制药业
Shanghai,Shanghai 72,184 位关注者
The global pharmaceutical and medical device open-access capability and technology platform
关于我们
- 所属行业
- 制药业
- 规模
- 超过 10,001 人
- 总部
- Shanghai,Shanghai
- 类型
- 上市公司
- 创立
- 2000
- 领域
- Drug Discovery、Bioanalytical、Lab Testing、Clinical and Regulatory、API Development and Manufacturing、Drug Development、Biological Reagents、Biologics、Medical Device、Chemistry、Toxicology、Cell and Gene Therapy和Contract Research Organization
地点
药明康德员工
动态
-
Thank you to our friends and colleagues who joined us yesterday for our 13th annual WuXi Global Forum at #JPM2025. Your presence and engagement reflect the true essence of our industry: a shared journey of knowledge, collaboration, and advancement for patients. We are especially grateful to our distinguished panelists and executive roundtable hosts for sharing their insights and expertise. Your contributions continue to push the boundaries of innovation and collaboration within the global healthcare community. It was inspiring to hear witness the collective wisdom, forward-thinking ideas, and partnerships that emerged during the Forum’s more than 120 executive roundtables. Together, we are advancing new solutions that will shape the future of healthcare.
-
We're pleased to announce that WuXi AppTec has joined the Pharmaceutical Supply Chain Initiative (#PSCI) as a Supplier Partner! This underscores the company’s enduring commitment to responsible business practices and supply chain resilience. By adhering to PSCI standards and enhancing our value chain management, we remain dedicated to supporting our customers in delivering innovative new therapies to #patients, working together towards a healthier and more sustainable future. Read more: https://lnkd.in/ejzC-esU
-
-
Entering its 13th year, the WuXi Global Forum will be held next week in #SanFrancisco during the 2025 J.P. Morgan Healthcare Conference. This year's event will kick off with "State of Innovation" followed by more than 100 Executive Roundtables. At the Forum, Every Innovation Story Matters. https://lnkd.in/eMjM_BtF
-
We are proud to announce WuXi AppTec has been listed as one of TIME’s Best Companies in Sustainable Growth of 2025! This recognition underscores our continued dedication to embedding #ESG into every aspect of our operations – to better develop therapies for greater positive impact for patients and the healthcare industry. Read more: https://lnkd.in/eMVWghg8
-
-
As we welcome 2025, we are filled with gratitude for our incredible customers, partners, and the entire #healthcare community. Your trust, support, and collaboration are the driving force behind our progress. We are excited to continue our work, enabling those working to innovate and develop treatments for patients around the world. May 2025 bring you health, happiness, and renewed inspiration. We can’t wait to achieve more, together.
-
-
We are delighted to share that WuXi AppTec has been recognized by S&P Dow Jones Indices in Sustainability (DJSI) for the fourth consecutive year! We are featured in both the 2024 DJSI World and the 2024 DJSI Emerging Markets. This is an acknowledgment of our ongoing commitment to #sustainability and the integration of responsible practices across our operations. We will continue to emphasize our #ESG commitment while supporting our customers who develop and deliver innovative new therapies to patients worldwide. Read more: https://lnkd.in/eqjyZn33
-
-
As we celebrate the holiday season, we are deeply grateful for our customers, partners, and colleagues around the globe. Your trust, collaboration, and unwavering support have been the foundation of everything we’ve achieved together in 2024. This season reminds us of the values we cherish most—connection, innovation, and the shared commitment to transforming lives. Through our unique #CRDMO model and the passion of our global team, we’ve continued to enable our partners to bring hope to patients in need. From all of us at WuXi AppTec, we wish you and your loved ones a joyful holiday season filled with warmth, peace, and togetherness. Here’s to another year of making a difference, together.
-
-
This December marks WuXi AppTec’s 24th anniversary! For 24 years, our belief that “every drug can be made and every disease can be treated” has continued to inspire us as we look to the future with determination and optimism. Starting from a single laboratory, we have grown into a global enterprise with 32 R&D and manufacturing sites worldwide, dedicated to advancing breakthroughs in life-sciences. Thank you to our customers, partners, and global teams - your commitment to our mission of enabling transformative solutions has been the heartbeat of our success. Together, we’re not just imagining a healthier world - we are building it.
-
-
As we mark Thanksgiving in the United States, we wanted to extend our gratitude to our global teams for their dedication and to our customers worldwide for their continued trust and support. Together, we are driving innovation, bringing hope and advancements to patients, striving towards a healthier world. This season is a reminder of our shared goals and the positive impact we make together. Happy #Thanksgiving to those in the United States!
-